Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Carbon Biosciences emerges with a new viral vector to shake up the cystic fibrosis gene therapy field
Nia JulianJune 21, 2022
Facebook0 Twitter Pinterest0 0 Likes
Previous

Kezar's phase 2 lupus data spur hope for former pipeline-in-a-drug contender—and a share rally

Nia JulianJune 29, 2022
Next

ASCO: ‘Any way you slice’ it, Arcellx's CAR-T is matching J&J-Legend’s Carvykti, analyst says

Nia JulianJune 9, 2022

© 2020 Solasta Ventures. All Rights Reserved.